Abstract
Breathing movements are initiated and controlled by a neuronal network within the lower brainstem that is influenced by peripheral and suprapontine inputs. To provide adaptation of breathing to vocalisation, exercise or hypoxia, rhythmogenic neurons of the ventral respiratory group (VRG) within the ventrolateral medulla (VLM) are controlled by numerous neuromodulators. Underlying cellular mechanisms are currently analysed in respiratory active medulla preparations from perinatal rodents. This reveals properties of the perinatal respiratory network pivotal for understanding spontaneous or drug-induced perturbation of breathing in preterm and term infants. Already at birth, ligand-gated anion channels can inhibit VLM-VRG neurons. But impairment of Cl- extrusion by hormones or growth factors may interfere with respiratory functions. During severe hypoxia, resulting in anoxia of the VLM-VRG, perinatal respiratory activity persists for more than twenty minutes, although at a greatly reduced frequency. This frequency depression, associated with a hyperpolarisation of rhythmogenic VLM-VRG neurons, is reversed by K+ channel blockers, thyrotropin-releasing hormone or substance-P, for example. This response may represent an adaptive mechanism for energy conservation during oxygen depletion. Endogenous frequency depression of the normoxic perinatal respiratory rhythm, possibly mediated by endorphins or prostaglandins, may serve to dampen excessive respiratory activity in utero. Opiates and prostaglandins, known to impair breathing in infants during clinical administration, likely act directly to depress rhythmogenic VLM-VRG neurons. Based upon such findings in perinatal rodent models on synaptic inhibition and responses to hypoxia-anoxia or clinically-applicable drugs, novel pharmacological strategies are discussed that aim to stabilise infant breathing by targeting rhythmogenic respiratory neurons.
Keywords: apnoea, anoxia, burster neurons, neuromodulation, rhythmogenesis
Current Neuropharmacology
Title: Neuromodulation of the Perinatal Respiratory Network
Volume: 2 Issue: 2
Author(s): Klaus Ballanyi
Affiliation:
Keywords: apnoea, anoxia, burster neurons, neuromodulation, rhythmogenesis
Abstract: Breathing movements are initiated and controlled by a neuronal network within the lower brainstem that is influenced by peripheral and suprapontine inputs. To provide adaptation of breathing to vocalisation, exercise or hypoxia, rhythmogenic neurons of the ventral respiratory group (VRG) within the ventrolateral medulla (VLM) are controlled by numerous neuromodulators. Underlying cellular mechanisms are currently analysed in respiratory active medulla preparations from perinatal rodents. This reveals properties of the perinatal respiratory network pivotal for understanding spontaneous or drug-induced perturbation of breathing in preterm and term infants. Already at birth, ligand-gated anion channels can inhibit VLM-VRG neurons. But impairment of Cl- extrusion by hormones or growth factors may interfere with respiratory functions. During severe hypoxia, resulting in anoxia of the VLM-VRG, perinatal respiratory activity persists for more than twenty minutes, although at a greatly reduced frequency. This frequency depression, associated with a hyperpolarisation of rhythmogenic VLM-VRG neurons, is reversed by K+ channel blockers, thyrotropin-releasing hormone or substance-P, for example. This response may represent an adaptive mechanism for energy conservation during oxygen depletion. Endogenous frequency depression of the normoxic perinatal respiratory rhythm, possibly mediated by endorphins or prostaglandins, may serve to dampen excessive respiratory activity in utero. Opiates and prostaglandins, known to impair breathing in infants during clinical administration, likely act directly to depress rhythmogenic VLM-VRG neurons. Based upon such findings in perinatal rodent models on synaptic inhibition and responses to hypoxia-anoxia or clinically-applicable drugs, novel pharmacological strategies are discussed that aim to stabilise infant breathing by targeting rhythmogenic respiratory neurons.
Export Options
About this article
Cite this article as:
Ballanyi Klaus, Neuromodulation of the Perinatal Respiratory Network, Current Neuropharmacology 2004; 2 (2) . https://dx.doi.org/10.2174/1570159043476828
| DOI https://dx.doi.org/10.2174/1570159043476828 |
Print ISSN 1570-159X |
| Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
Call for Papers in Thematic Issues
Advances and Integrative Approaches to Gut-Brain Interactions
Disorders of gut-brain interaction (DGBIs), formerly known as functional gastrointestinal disorders, involve dysfunction of complex signaling pathways between the gastrointestinal tract and the central nervous system. These disorders span the esophagus (functional heartburn, functional dysphagia), stomach (functional dyspepsia), and intestines (irritable bowel syndrome, chronic constipation), and are increasingly recognized as ...read more
Advances in Neuroimaging: Bridging Pharmacology, Nanotechnology, and Neurological Disorders
This special topic seeks to compile cutting-edge research and reviews that explore the synergy between neuroimaging, pharmacology, and nanotechnology in understanding and treating neurological disorders. We aim to elucidate novel imaging biomarkers for tracking drug efficacy and disease progression in conditions such as Alzheimer’s, Parkinson’s, multiple sclerosis, and brain tumors. ...read more
Advances in Neurovascular Unit in Stroke and Neurodegenerative Disease: Mechanisms and Therapeutic Frontiers
The main goal of this special issue is to analyze current knowledge of the functional roles of various types of cells in neurovascular units(NVU) in neurodegenerative diseases such as stroke, Alzheimer's disease, and Parkinson's disease. This issue invites research on the cellular and molecular mechanisms driving inflammation, blood-brain barrier(BBB) injury, ...read more
Cannabinoids in Health and Disease.
The role of cannabinoids in human physiology and disease has become a dynamic and rapidly evolving field of research, offering new insights into the potential of these compounds. With advancements in neuropharmacology and clinical trials, cannabinoids are now at the forefront of innovative approaches to treat several conditions. This special ...read more
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Serum Pro-oxidant-antioxidant Balance in Subjects with Type 2 Diabetes Mellitus
Combinatorial Chemistry & High Throughput Screening Is there an Association Between Periodontitis and Atherosclerosis in Adults? A Systematic Review
Current Vascular Pharmacology Immunophilins in Nervous System Degeneration and Regeneration
Current Topics in Medicinal Chemistry APOE Genotypes and Brain Imaging Classes in Normal Cognition, Mild Cognitive Impairment, and Alzheimer’s Disease: A Longitudinal Study
Current Alzheimer Research Renin-Angiotensin System and Alzheimer’s Disease Pathophysiology: From the Potential Interactions to Therapeutic Perspectives
Protein & Peptide Letters Levosimendan: From Basic Science to Clinical Trials
Recent Patents on Cardiovascular Drug Discovery EDITORIAL (Thematic Issue: Preeclampsia and Modern Approaches to Diagnosis and Therapy)
Current Women`s Health Reviews Arterial Stiffness, Cognitive Dysfunction and Adherence to Antihypertensive Agents. Is there a Link to Hypertensive Patients?
Current Vascular Pharmacology Long-term Etanercept Therapy Favors Weight Gain and Ameliorates Cachexia in Rheumatoid Arthritis Patients: Roles of Gut Hormones and Leptin
Current Pharmaceutical Design Challenges and Solutions in the Development of Genomic Biomarker Panels: A Systematic Phased Approach
Current Genomics Cytoprotection by Natural and Synthetic Polyphenols in the Heart: Novel Mechanisms and Perspectives
Current Pharmaceutical Design Targeting Enteric Neurons and Plexitis for the Management of Inflammatory Bowel Disease
Current Drug Targets Effect of Methylxanthine Derivatives on Doxorubicin Transport and Antitumor Activity
Current Drug Metabolism Cardiovascular Effects of the Phytoestrogen Genistein
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Cardiovascular Manifestations of COVID-19
Current Cardiology Reviews Neonatal Necrotizing Enterocolitis – Inflammation and Intestinal Immaturity
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Venom Peptide Modulators of the Immune System
Inflammation & Allergy - Drug Targets (Discontinued) Metabolomics by Imaging; Biochemical-Magnetic Resonance Correlation: What We Learn from Combined Data of Magnetic Resonance Spectroscopy, NMR Spectroscopy, Clinical Chemistry and Tissue Content Analysis? Major Bottlenecks in Diagnosis
Recent Patents on Medical Imaging A Diabetes Treatment Strategy to Reduce the Risk of Cardiovascular Events: Clinical Benefits and Potential of Linagliptin
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) The State of the Art in Anti-Malarial Drug Discovery and Development
Current Topics in Medicinal Chemistry





